Quidelortho Corp Intrinsic Stock Value – Geode Capital Management LLC Reduces Investment in QuidelOrtho Co.

🌥️Trending News

QUIDELORTHO ($NASDAQ:QDEL): Geode Capital Management LLC recently revealed that it has reduced its majority stake in QuidelOrtho Co, a medical product and services provider. The investment arm of the Defense World has decreased its sizable holding in the publicly-traded company. QuidelOrtho Corp is a leading provider of orthopedic products and services. The company offers a wide range of innovative medical solutions for orthopedic surgery, sports medicine, and general orthopedic care. They have developed groundbreaking products and services specifically designed to meet the needs of orthopedic surgeons, physical therapists, and other healthcare professionals. QuidelOrtho has extensive experience in providing top-of-the-line medical solutions that address the unique needs of orthopedic care providers.

They are a leader in developing evidence-based orthopedic products that have become the benchmark for orthopedic care providers worldwide. QuidelOrtho not only provides superior products and services, but also offers comprehensive customer support. Their knowledgeable and experienced staff is dedicated to helping customers with their medical needs. Through their commitment to customer service, QuidelOrtho aims to provide outstanding customer care and satisfy the needs of orthopedic care providers worldwide.

Market Price

On Monday, QUIDELORTHO CORP saw a decrease in its stock value after Geode Capital Management LLC reported that they had reduced their investment in the company. QUIDELORTHO CORP’s stock opened at $84.7 and closed at $84.2, down by 0.6% from the prior closing price of 84.7. It is unclear why Geode Capital Management LLC has reduced their investment in QUIDELORTHO CORP; however, investors are closely watching the company’s performance in the coming weeks. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Quidelortho Corp. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Quidelortho Corp. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Quidelortho Corp. More…

Key Ratios Snapshot

Some of the financial key ratios for Quidelortho Corp are shown below. More…

Analysis – Quidelortho Corp Intrinsic Stock Value

At GoodWhale, we recently conducted an analysis of QUIDELORTHO CORP‘s wellbeing. Our proprietary Valuation Line technology allowed us to accurately gauge the fair value of QUIDELORTHO CORP shares to be around $146.3. However, we noticed the current stock price of QUIDELORTHO CORP is traded at $84.2, which is substantially lower than the fair market value, undervaluing the company by 42.4%. Our analysis suggests that there could be significant potential for growth and value appreciation with QUIDELORTHO CORP. More…

Peers

Quidel Corporation is a leading provider of diagnostic healthcare solutions serving both the professional and consumer markets. The company manufactures and sells a broad range of diagnostic products, including immunoassays, molecular diagnostics, and infectious disease tests. Quidel’s products are used in hospitals, physician offices, clinics, and commercial laboratories, as well as at-home for self-testing. Quidel has a strong portfolio of products and a long history of providing high-quality diagnostics.

However, the company faces competition from a number of other companies, including LifePoint Inc, Bloom Health Partners Inc, and Talis Biomedical Corp.

– LifePoint Inc ($OTCPK:LFPI)

LifePoint Inc is a company that provides healthcare services. It has a market cap of 10.21k as of 2022 and a Return on Equity of 8.83%. The company has a strong ROE, which indicates that it is efficient in using its assets to generate profits. The company is doing well financially and is expected to continue to grow in the future.

– Bloom Health Partners Inc ($OTCPK:BLMHF)

The company’s market cap is 2.86M as of 2022. The company’s ROE is 26.8%. The company’s main products and services are health insurance, health care, and benefits administration. Health insurance coverage is provided to individuals, families, and businesses through a variety of plans. Health care services are delivered through a network of providers. Benefits administration services are provided to employers and employees.

– Talis Biomedical Corp ($NASDAQ:TLIS)

Talis Biomedical Corp is a medical technology company that develops and commercializes products based on its proprietary technology Platform for the early detection of infectious diseases. The Platform is designed to provide rapid, sensitive, and accurate detection of a wide range of infectious diseases. Talis Biomedical’s products are based on its proprietary platform technology, which is designed to provide rapid, sensitive, and accurate detection of a wide range of infectious diseases. Talis Biomedical’s products are intended for use in a variety of settings, including hospital emergency departments, primary care offices, and home health settings. Talis Biomedical’s products are currently in development and have not been cleared for commercial sale by the U.S. Food and Drug Administration.

Summary

QuidelOrtho Corp. has seen a reduction in its stake held by Geode Capital Management LLC. Such a move could indicate that Geode is bearish on QuidelOrtho’s prospects going forward. Investors should do further research into the company to assess its long-term potential and determine whether or not the stock is currently undervalued. Analysts should also consider the company’s financial position, competitive landscape, and other factors that could influence stock price movements.